.Merck defeats revenues expectations, raises purchases overview on sturdy need for best medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Income Forecasts as Keytruda Purchases Surge BloombergMerck Stock: Pharma Titan Posts Powerful End Results, Yet Overview Tumbles Short Real estate investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats earnings and purchases assumptions amid Keytruda asset, but supplies combined full-year outlook MarketWatch.